Scientific publications

Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis

Azcona C [SP], Alzina V, Barona P, Sierrasesúmaga L, Villa-Elízaga I.
Department of Paediatrics, University Clinic of Navarra, Faculty of Medicine, Pamplona, Spain.

Magazine: European Journal of Pediatrics

Date: Mar 1, 1994

Pediatrics [SP]

Abstract
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.

CITATION  Eur J Pediatr. 1994 Mar;153(3):164-6

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra